Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Wanleng Deng

ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties

Molecular Cancer Research

Cancer Research

Molecular Biology

English

Related publications

Carcinoma of Unknown Primary With EML4‐ALK Fusion Response to ALK Inhibitors

Cancer Research

English

Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer

Journal of Clinical Oncology

Cancer Research

English

Variable Response to ALK Inhibitors in NSCLC With a Novel MYT1L-ALK Fusion

Journal of Thoracic Oncology

Respiratory Medicine

English

A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib

Journal of Thoracic Oncology

Respiratory Medicine

English

Dramatic Response to Alectinib in a Lung Cancer Patient With a Novel VKORC1L1-ALK Fusion and an Acquired ALK T1151K Mutation

Lung Cancer: Targets and Therapy

English

Early and Late Effects of Pharmacological ALK Inhibition on the Neuroblastoma Transcriptome

English

Dual Inhibition of IGF-IR and ALK as an Effective Strategy to Eradicate NPM-ALK+ T-Cell Lymphoma

Journal of Hematology and Oncology

Cancer Research

Molecular Biology

English

Prognostic Significance of NPM-ALK Fusion Transcript Overexpression in ALK-positive Anaplastic Large-Cell Lymphoma

Modern Pathology

Forensic Medicine

English

P115 Clinical Outcome of Crizotinib in Diverse ALK Fusion Partners and Different Detection Methods Treatment Naïve Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English